Polymerase chain reaction (PCR) has revolutionized the field of molecular diagnostics since its conception in 1983. Roche has played a pioneering role from the start.
This innovative, Nobel-prize winning, technology allows clinicians to diagnose infectious disease, detect genetic variations and mutations, or track down the source of a viral infection – all from the DNA or RNA contained in a single cell or patient sample such as blood, skin cells, saliva or hair.
Polymerase chain reaction (PCR) has revolutionized the field of molecular diagnostics since its conception in 1983. Roche has played a pioneering role from the start.
From reverse transcription to real-time PCR, Roche is behind many of the key advancements in the field of polymerase chain reaction technology.